Environmental and lifestyle risk factors of gastric cancer

Archives of Iranian Medicine

Volumn 16, Issue 6, 2013, Pages 358-365

  Lee, Yeong Yeh ^a,b   Derakhshan, Mohammad H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Environmental; Lifestyle; Risk factor; Stomach cancer

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; IRON; OMEGA 3 FATTY ACID; TRACE ELEMENT;

ALCOHOL CONSUMPTION; BROCCOLI; CANCER INCIDENCE; CANCER RISK; COFFEE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FISH; FOOD INTAKE; FOUNDRY; FRUIT; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HONEY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JC VIRUS; LIFESTYLE; NUTRITIONAL ASSESSMENT; OBESITY; PEPPER; PHYSICAL ACTIVITY; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SALT INTAKE; SMOKING; STOMACH CANCER; TEA; VEGETABLE; WORKER;

ALCOHOL DRINKING; DIET; ENVIRONMENT; FOOD; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIFE STYLE; MOTOR ACTIVITY; OBESITY; RISK FACTORS; SMOKING; SODIUM CHLORIDE, DIETARY; STOMACH NEOPLASMS;

EID: 84878868786     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Lambert R, Saito H, Lucas E, Sankaranarayanan R. Survival from digestive cancer in emerging countries in Asia and Africa. Eur J Gastroenterol Hepatol. 2012; 24: 605-612.
3. Sonnenberg A. Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut. 2010; 59: 736-743.
4. Susser M, Stein Z. Civilisation and peptic ulcer. Lancet. 1962; 1: 115-119.
5. Kidd M, Modlin IM. A century of Helicobacter pylori: paradigms lost-paradigms regained. Digestion. 1998; 59: 1-15.
6. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1: 1311-1315.
7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Eng J Med. 2001; 345: 784-789.
8. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. 2011; 22: 375-387.
9. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol. 2007; 102: 1789-1798.
10. Derakhshan MH, Lee YY. Gastric cancer prevention through eradication of Helicobacter pylori infection: feasibility and pitfalls. Arch Iran Med. 2012; 15: 662-663.
11. Pandeya N, Whiteman DC; Australian Cancer Study. Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community. J Gastroenterol Hepatol. 2011; 26: 1283-1289.
12. Lee YY, Mahendra Raj S, Graham DY. Helicobacter pylori infection-A boon or a bane: lessons from studies in a low prevalence population. Helicobacter. 2013 Apr 22. doi: 10.1111/hel.12058 [Epub ahead of print].
13. Raj SM, Lee YY, Choo KE, Noorizan AM, Zulkifli A, Radzi M, et al. Further observations in an area with an exceptionally low prevalence of Helicobacter pylori infection. Trans R Soc Trop MedHyg. 2008; 102: 1163-1164.
14. Yeh LY, Raj M, Hassan S, Aziz SA, Othman NH, Mutum SS, et al. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian J Gastroenterol. 2009; 28: 49-52.
15. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y Helicobacter pylori infection in intestinal-and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991; 83: 640-643.
16. Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008; 57: 298-305.
17. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007; 56: 918-925.
18. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, Nouraie M, Yazdanbod A, Tavangar SM, et al. Critical role ofHelicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci. 2008; 53: 27-33.
19. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012; 13: 2-9.
20. David S, Meltzer SJ. Stomach-Genetic and epigenetic alterations of preneoplastic and neoplastic lesions. Cancer Biomark. 2010; 9: 493-507.
21. Maran S, Lee YY, Xu S, Rajab N, Hasan N, Syed Abdul Aziz SH, et al. Gastric precancerous lesions are associated with gene variants in Helicobacter pylori-susceptible ethnic Malays. World J Gastroenterol. 2013 [in press].
22. Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis, 2013 [Epub ahead of print].
23. Hosseini E, Poursina F, de Wiele TV, Safaei HG, Adibi P. Helicobacter pylori in Iran: a systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci. 2012; 17: 280-292.
24. Yamaoka Y. Pathogenesis of Helicobacter pylori-related gastroduodenal diseases from molecular epidemiological studies. Gastroenterol Res Pract. 2012; 2012: 371503.
25. Raju, D, Hussey S, Ang M, Terebiznik MR, Sibony M, Galindo-Mata E, et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology. 2012; 142: 1160-1171.
26. Wang P, Zhang L, Jiang JM, Ma D, Tao HX, Yuan SL, et al. Association of NODI and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. World J Gastroenterol. 2012; 18: 2112-2120.
27. Li Y Dai L, Zhang J, Wang P, Chai Y, Ye H, et al. Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population. Oncol Lett. 2012; 3: 107-112.
28. Wang X, Yang J, Ho B, Yang Y, Huang Z, Zhang Z, et al. Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients. Helicobacter. 2009; 14: 114-119.
29. Kim J, Cho YA, Choi IJ, Lee YS, Kim SY, Shin A, et al. Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of non-cardia gastric cancer. PLoS One. 2012; 7: e29643.
30. Saberi S, Zendehdel K, Jahangiri S, Talebkhan Y, Abdirad A, Mohajerani N, et al. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection. IranBiomed J. 2012; 16: 179-184.
31. Rafiei A, Hosseini V, Janbabai G, Fazli B, Ajami A, Hosseini-Khah Z, et al. Inducible nitric oxide synthetase genotype and Helicobacter pylori infection affect gastric cancer risk. World J Gastroenterol. 2012; 18: 4917-4924.
32. Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology. 2013; 144: 122-133.
33. Jiang J, Jia Z, Cao D, Jin MS, Kong F, Suo J, et al. Polymorphisms ofthe DNA methyltransferase 1 associated with reduced risks of Helicobacter pylori infection and increased risks of gastric atrophy. PLoS One. 2012; 7: e46058.
34. Goto Y, Hagikura S, Katsuda N, Hamajima N. A C to T polymorphism of urokinase plasminogen activator (P141L) is associated with Helico-bacterpylori infection. Asian Pac J Cancer Prev. 2011; 12: 803-806.
35. Maran S, Lee YY, Xu S, Raj SM, Noorizan AM, Choo KE, et al. Toward understanding the low prevalence of Helicobacter pylori infection in Malays: genetic variants differ among Helicobacter pylori negative ethnic Malays in the north-eastern region of Peninsular Malaysia and Han Chinese and South Indians. J Dig Dis. 2013; 14: 196-202.
36. Sokolova O, Vieth M, Naumann M. Protein Kinase C isozymes regulate matrix metalloproteinase-1 expression and cell invasion in Helicobacter pylori infection. Gut. 2013; 62: 358-367.
37. Doll R, Peto R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005; 92: 426-429.
38. Gonzalez CA, Pera G, Aqudo A, Palli D, Krogh V, Vineis P, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into cancer and Nutrition (EPIC). Int J Cancer. 2003; 107: 629-634.
39. Koizumi Y, Tsubono Y, Nakaya N, Kuriyama S, Shibuya D, Matsuoka H, et al. Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan. Int J Cancer. 2004; 112: 1049-1055.
40. La Torre G, Chiaradia G, Gianfagna F, De Lauretis A, Boccia S, Mannocci A, et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Turnon. 2009; 95: 13-22.
41. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008; 19: 689-701.
42. Sjodahl K, Lu Y, Nilsen TI, Ye W, Hveem K, Vatten L, et al. Smoking and alcohol dinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer. 2007; 120: 128-132.
43. Moy KA, Fan Y, Wang R, Gao YT, Yu MC, Yuan JM. Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2287-2297.
44. Duan L, Wu AH, Sullivan-Halley J, Berstein L. Passive smoking and risk of oesophageal and gastric adenocarcinomas. Br J Cancer. 2009; 100: 1483-1485.
45. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M et al. Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer. 2013 [Epub ahead of print].
46. Freedman ND, Derakhshan MH, Abnet CC, Schatzkin A, Hollenbeck AR, McColl KE. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010; 46: 2473-2478.
47. Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D, McColl KE. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut. 2009; 58: 16-23.
48. Wang H, Ma L, Li Y, Cho CH. Exposure to cigarette smoke increases apoptosis in the rat gastric mucosa through a reactive oxygen species-mediated and p53-independent pathway. Free Radic Biol Med. 2000; 28: 1125-1131.
49. Kneller RW, You WC, Chang YS, Liu WD, Zhang L, Zhao L, et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst. 1992; 84: 1261-1266.
50. Sato T, Fukuyama T, Suzuki T, Takayanagi J, Murakami T, Shiotsuki N, et al. Studies of causation of gastric cancer 2. The relation between gastric cancer mortality rate and salted food intake in several places in Japan. Bull Inst Public Health. 1959; 8: 187-198.
51. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci. 2005; 96: 1-6.
52. D' Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012; 31: 489-498.
53. Palli D. Gastric cancer and Helicobacter pylori: a critical evaluation of the epidemiological evidence. Helicobacter. 1997; 2 (suppl 1): S50-S55.
54. Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol. 2009; 15: 2204-2213.
55. Shibata T, Tahara T, Arisawa T, Hirata I. Polymorphism of the salt sensitivity gene angiotensinogen and gastric cancer risk. Mol MedRep. 2011; 4: 723-726.
56. IARC monographs on the evaluation of carcinogenic risks to humans, Volume 96 Alcohol Consumption and Ethyl Carbamate. Lyon: World Health Organization, International Agency for Research on Cancer (IARC); 2010
57. Duell EJ, Travier N, Lujan-Barraso L, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, et al. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr. 2011; 94: 1266-1275.
58. Moy KA, Fan Y, Wang R, Gao YT, Yu MC, Yuan JM. Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2287-2297.
59. Tramacere I, Negri E, Pelucchi C, Bagnardi V Rota M, Scotti L, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012; 23: 28-36.
60. Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. MutatRes. 2005; 591: 34-44.
61. Shin CM, Kim N, Cho SI, Kim JS, Jung HC, Song IS. Association between alcohol intake and risk for gastric cancer with regard to ALDH2 genotype in the Korean population. Int J Epidemiol. 2011; 40: 1047-1055.
62. Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K Rautemaa R, Gronroos L, et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol. 2007; 43: 181-186.
63. González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst. 2006; 98: 345-354.
64. Jaksyn P, Agudo A, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Navarro C, et al. Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study. Int J Cancer. 2012; 130: 2654-2663.
65. Cook MB, Kamangar F, Weinstein SJ, Albanes D, Virtamo J, Taylor PR, et al. Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev. 2012; 21: 2033-2042.
66. Lopez-Carillo L, Lopez-Cervantes M, Ward MH, Bravo-Alvarado J, Ramirez-Espitia A. Nutrient intake and gastric cancer in Mexico. Int J Cancer. 1999; 83: 601-605.
67. Cornee J, Pobel D, Riboli E, Guyader M, Hemon B. A case-control study of gastric cancer and nutritional factors in Marseille, France. Eur J Epidemiol. 1995; 11: 55-65.
68. Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, et al. Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Am J Clin Nutr. 2011; 94: 1304-1313.
69. Bonequi P, Meneses-Gonzalez F, Correa P, Rabkin CS, Camargo MC. Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control. 2013; 24: 217-231.
70. Mathew A, Gangadharan P, Varghese C, Nair MK. Diet and stomach cancer: a case-control study in South India. Eur J Cancer Prev. 2000; 9: 89-97.
71. Bley K, Boorman G, Mohammad B, McKenzie D, Babbar S. A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin. Toxicol Pathol. 2012; 40: 847-873.
72. González CA, Pera G, Aqudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer. 2006; 118: 2559-2566.
73. Serafini M, Bellocco R, Wolk A, Ekstrom AM. Total antioxidant potential of fruit and vegetables and risk of gastric cancer. Gastroenterology. 2002; 123: 985-991.
74. Navarro-Alarcon M, Cabrera-Vique C. Selenium in food and the human body: a review. Sci Total Environ. 2008; 400: 115-141.
75. Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology. 2010; 138: 1704-1713.
76. Nouarie M, Pourshams A, Kamangar F, Sotoudeh M, Derakhshan MH, Akbari MR, et al. Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol. 2004; 10: 2544-2546.
77. Jackson MI, Combs GF Jr. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin NutrMetab Care. 2008; 11: 718-726.
78. Jenab M, Riboli E, Ferrari P, Sabate J, Slimani N, Norat T, et al. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis. 2006; 27: 2250-2257.
79. Kodama K, Sumii K, Kawano M, Kido T, Nojima K, Sumii M, et al. Gastric juice nitrite and vitamin C in patients with gastric cancer and atrophic gastritis: is low acidity solely responsible for cancer risk? Eur J Gastroenterol Hepatol. 2003; 15: 987-993.
80. Kim DS, Lee MS, Kim YS, Kim DH, Bae JM, Shin MH, et al. Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori. Eur J Epidemiol. 2005; 20: 67-71.
81. You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000; 92: 1607-1612.
82. Campos FI, Koriyama C, Akiba S, Carrasquilla G, Serra M, Carrascal E, et al. Toenail zinc level and gastric cancer risk in Cali, Colombia. J Cancer Res Clin Oncol. 2008; 134: 169-178.
83. Nakaji S, Fukuda S, Sakamoto J, Sugawara K, Shimoyama T, Umeda T, et al. Relationship between mineral and trace element concentrations in drinking water and gastric cancer mortality in Japan. Nutr Cancer. 2001; 40: 99-102.
84. Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La Vecchia C. Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study. Ann Oncol. 2009; 20: 160-165.
85. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991; 54: 438-463.
86. Wu S, Liang J, Zhang L, Zhu X, Liu X, Miao D. Fish consumption and the risk of gastric cancer: systematic review and meta-analysis. BMC Cancer. 2011; 11: 26.
87. Gallus S, Tramacere I, Tavani A, Bosetti C, Bertuccio P, Negri E, et al. Coffee, black tea and risk of gastric cancer. Cancer Causes Control. 2009; 20: 1303-1308.
88. Myung SK, Bae WK, Oh SM, Kim Y, Ju W, Sung J, et al. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer. 2009; 124: 670-677.
89. Lee YY, Ismail AW, Mustaffa N, Musa KI, Majid NA, Choo KE, et al. Sociocultural and dietary practices among Malay subjects in the north-eastern region of Peninsular Malaysia: a region of low prevalence of Helicobacter pylori infection. Helicobacter. 2012; 17: 54-61.
90. Keenan JI, Salm N, Wallace AJ, Hampton MB. Using food to reduce H. pylori-associated inflammation. PhytotherRes. 2012; 26: 1620-1605.
91. Hsieh PS, Tsai YC, Chen YC, Teh SF, Ou CM, King VA. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter. 2012; 17: 466-477.
92. Stukonis M, Doll R. Gastric cancer in man and physical activity at work. Int J Cancer. 1969; 4: 248-254.
93. Severson RK, Nomura AM, Grove JS, Stemmermann GN. A prospective analysis of physical activity and cancer. Am J Epidemiol. 1989; 130: 522-529.
94. Vigen C, Bernstein L, Wu AH. Occupational physical activity and risk of adenocarcinomas of the esophagus and stomach. Int J Cancer. 2006; 118: 1004-1009.
95. Huerta JM, Navarro C, Chirlaque MD, Tormo MJ, Steindorf K, Buckland G, et al. Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC cohort. Cancer Causes Control. 2010; 21: 657-669.
96. Sjödahl L, Jia C, Vatten L, Nilsen T, Hveem K, Lagergren J. Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev. 2008; 17: 135-140.
97. Renehan AG, Soerjomataram I, Leitzmann MF. Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe. Eur J Cancer. 2010; 46: 2581-2592.
98. Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009; 45: 2867-2873.
99. Watabe H, Mitsushima T, Derakhshan MH, Yamaji Y, Okamoto M, Kawabe T, et al. Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10,197 Japanese subjects. Dig Dis Sci. 2009; 54: 988-995.
100. Coggon D, Barker DJ, Cole RB. Stomach cancer and work in dusty industries. Br J IndMed. 1990; 47: 298-301.
101. Xu Z, Pan GW, Liu LM, Brown LM, Guan DX, Xiu Q, et al. Cancer risks among iron and steel workers in Anshan, China, Part 1: Proportional mortality ratio analysis. Am J IndMed. 1996; 30: 1-6.
102. Xu Z, Brown LM, Pan GW, Liu TF, Gao GS, Stone BJ, et al. Cancer risks among iron and steel workers in Anshan, China, Part II: case-control studies of lung and stomach cancer. Am J IndMed. 1996; 30: 7-15.
103. Ahn YS, Won JU, Park RM. Cancer morbidity of foundry workers in Korea. J Korean Med Sci. 2010; 25: 1733-1741.
104. Wu CW, Wei YY, Chi CW, Lui WY, P'Eng FK, Chung C. Tissue potassium, selenium, and iron levels associated with gastric cancer progression. DigDis Sci. 1996; 41: 119-125.
105. Conte D, Piperno A, Mandelli C, Fargion S, Cesana M, Brunelli L, et al. Clinical, biochemical, and histological features of primary haemochro-matosis: a report of 67 cases. Liver. 1986; 6: 310-315.
106. Hattori H. High prevalence of haemosiderin accumulation in the cytoplasm of gastric glands in patients with liver cirrhosis. J Clin Pathol. 2004; 57: 621-624.
107. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004; 4: 757-768.
108. Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009; 137: 824-833.
109. Matsumoto S, Yamasaki K, Tsuji K, Shirahama S. Human T lympho-tropic virus type 1 infection and gastric cancer development in Japan. J InfectDis. 2008; 198: 10-15.
110. White MK, Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology. 2004; 324: 1-16.
111. Murai Y, Zheng HC, Abdel Aziz HO, Mei H, Kutsuna T, Nakanishi Y et al. High JC virus load in gastric cancer and adjacent non-cancerous mucosa. Cancer Sci. 2007; 98: 25-31.
112. Kreuzer M, Straif K, Marsh JW, Dufey F, Grosche B, Nosske D, et al. Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946-2003. Occup Environ Med. 2012; 69: 217-223.
113. Goto H, Watanabe T, Miyao M, Fukuda H, Sato Y, Oshida Y. Cancer mortality among atomic bomb survivors exposed as children. Environ Health Prev Med. 2012; 17: 228-234.
114. Dong H, Jin X, Hu J, Li H, He X, Liu X, et al. High γ-radiation sensitivity is associated with increased gastric cancer risk in a Chinese Han population: a case-control analysis. PLoS One. 2012; 7: e43625.
115. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: URL: http://globocan.iarc.fr (Accessed on 15 May 2013)
116. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, et al. Helicobacter pylori in developing countries, WGO Practice Guideline. World Gastroenterology Organisation. Available from: URL: www.worldgas-troenterology.org (Access date: 15 May 2013)
117. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12: 576-583.